Lorazepam
- Product NDC
- 62135-549
- 11-digit product format
- 621350549
- Labeler code
- 62135
- Product ID
- 62135-549_044c464b-af13-d50f-e063-6394a90ade25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- CONCENTRATE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA079244
- Marketing category
- ANDA
- Marketing start
- 2009-04-28
- Substance
- LORAZEPAM
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lorazepam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LORAZEPAM | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O26FZP769L |
| Rxcui | 311376 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-549-43 | Lorazepam | 30 mL in 1 BOTTLE | CONCENTRATE | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-549 | LORAZEPAM CONCENTRATE [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20230902_e075c78d-f0c6-4380-b769-bb8833d23ba5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-549-43 | 62135054943 | 30 mL in 1 BOTTLE (62135-549-43) | 30 ml | 2023-04-20 | No | No | Current |